Related Experiment Video
Updated: Jun 3, 2026

06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Ceftriaxone induced thrombocytopenia in a child
1Department of Pediatric Hematology, Yuzuncu Yil University, Van, Turkey. drsinanakbayram@gmail.com
Bratislavske Lekarske Listy
|April 5, 2011
Summary
Ceftriaxone can rarely cause thrombocytopenia, a condition of low platelet count. This case highlights a rare presentation of drug-induced thrombocytopenia in a young child.
Area of Science:
- Hematology
- Pharmacology
- Pediatrics
Background:
- Thrombocytopenia, a low platelet count, can result from various causes including diseases, genetic factors, toxins, and medications.
- Antibiotics, particularly cephalosporins like ceftriaxone, are known to occasionally induce thrombocytopenia.
- Drug-induced thrombocytopenia is a significant adverse drug reaction requiring careful diagnosis.
Observation:
- A 2-year-old girl presented with clinical signs suggestive of thrombocytopenia.
- The patient had recently been treated with ceftriaxone.
- The presentation of ceftriaxone-induced thrombocytopenia in this pediatric case was unusual.
Findings:
- The case report details an instance of thrombocytopenia linked to ceftriaxone administration.
- Laboratory investigations confirmed a significant decrease in platelet count.
- Cessation of ceftriaxone led to the recovery of platelet levels, supporting a causal relationship.
Implications:
- This case underscores the importance of considering ceftriaxone as a potential cause of thrombocytopenia in pediatric patients.
- Clinicians should maintain a high index of suspicion for drug-induced thrombocytopenia, even with rare presentations.
- Awareness of such adverse drug reactions is crucial for patient safety and effective treatment strategies.
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)